AscellaHealth

AscellaHealth, centrally located in Berwyn, Pennsylvania, and extending its reach across the United States and Europe, is recognized as a leader in the specialty pharmacy and healthcare services industry. This organization is renowned for its bespoke, technologically advanced specialty pharmaceutical and healthcare management services. These services cater specifically to a diverse array of stakeholders, including payers, providers, life sciences companies, and patients, especially those suffering from complex, chronic conditions or rare diseases requiring specialized medications and innovative gene and cell therapies. Under the guidance of CEO and Co-founder Dea Belazi, AscellaHealth has evolved into a premier global provider of healthcare and specialty pharmacy solutions. With a team of over 200 professionals, Belazi leverages his extensive background as a registered pharmacist and seasoned executive to oversee the creation and administration of its customized, technology-enabled services. These services are critical in facilitating the successful launch and commercialization of specialty and rare disease medications aimed at significantly improving patient health outcomes. Bill Oldham, who joined Belazi in leadership, serves as the Chairman, President, and co-founder. Oldham's rich experience in fintech has critically shaped the strategic direction of AscellaHealth, particularly influencing the pharmacy benefit management (PBM) sector. His strategic insights have driven the company to achieve a staggering 1556% growth in revenue over four years through organic growth and strategic acquisitions. His leadership and financial acumen have been recognized with multiple awards, including the Philadelphia Business Journal's 2022 CFO of the Year and a place on the Philadelphia Titan 100 list for two consecutive years. AscellaHealth is committed to enhancing the healthcare journey for patients by improving access to specialty medications and optimizing clinical outcomes. The company provides a comprehensive suite of services that includes Pre-Commercialization and Market Access Solutions, Hub and Patient Support, Limited Distribution Drug Strategies, and a Proprietary Specialty Pharmacy and Infusion Network, all supported by advanced, technology-driven patient engagement and extensive medical and pharmacy benefit management systems. AscellaHealth's proactive approach in adapting its service offerings to meet the dynamic needs of the specialty pharmacy market establishes it as a critical partner in healthcare solutions. The company's dedication to innovation and excellence in service has consistently earned it accolades and recognition within the healthcare industry, solidifying its status as a leader in enhancing healthcare outcomes and patient care.